Last reviewed · How we verify

Pollutox (OZONE)

Deseret Biologicals, Inc. · FDA-approved active Small molecule Quality 16/100

Pollutox (generic name: OZONE) is a Radiographic Contrast Agent [EPC] Small molecule drug developed by Deseret Biologicals, Inc.. It is currently FDA-approved for nausea, fatigue, head discomfort.

At a glance

Generic nameOZONE
SponsorDeseret Biologicals, Inc.
Drug classRadiographic Contrast Agent [EPC]
ModalitySmall molecule
Therapeutic areaOther
PhaseFDA-approved

Approved indications

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Pollutox

What is Pollutox?

Pollutox (OZONE) is a Radiographic Contrast Agent [EPC] drug developed by Deseret Biologicals, Inc., indicated for nausea, fatigue, head discomfort.

What is Pollutox used for?

Pollutox is indicated for nausea, fatigue, head discomfort, abdominal discomfort.

Who makes Pollutox?

Pollutox is developed and marketed by Deseret Biologicals, Inc. (see full Deseret Biologicals, Inc. pipeline at /company/deseret-biologicals-inc).

What is the generic name of Pollutox?

OZONE is the generic (nonproprietary) name of Pollutox.

What drug class is Pollutox in?

Pollutox belongs to the Radiographic Contrast Agent [EPC] class. See all Radiographic Contrast Agent [EPC] drugs at /class/radiographic-contrast-agent-epc.

What development phase is Pollutox in?

Pollutox is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing